Cambridge, United Kingdom

Wendy A Williams

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wendy A Williams - Innovator in Neuropathic Pain Treatment

Introduction

Wendy A Williams is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biomedical research, particularly in the development of therapies for neuropathic pain. Her innovative work has led to the creation of a patent that addresses critical medical needs.

Latest Patents

Wendy A Williams holds a patent for "P2X4 antibodies and uses thereof." This invention provides antibodies that specifically bind to a P2X4 polypeptide and modulate P2X4 channel activity. The patent also includes recombinant P2X4 polypeptides and methods for generating such polypeptides. Additionally, it outlines compositions and methods for generating anti-P2X4 antibodies, as well as methods of using these antibodies for the treatment of neuropathic pain and other indications. She has 1 patent to her name.

Career Highlights

Wendy A Williams is associated with Medimmune Limited, where she has been instrumental in advancing research and development in her field. Her work has not only contributed to scientific knowledge but also has the potential to improve patient outcomes significantly.

Collaborations

Wendy collaborates with talented professionals in her field, including Clare Jones and James Button. These partnerships enhance the research and development process, leading to innovative solutions in healthcare.

Conclusion

Wendy A Williams is a key figure in the development of treatments for neuropathic pain, with her patent on P2X4 antibodies showcasing her innovative spirit. Her contributions to Medimmune Limited and collaborations with other professionals highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…